BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32040538)

  • 1. Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study.
    Richard MA; Lupo PJ; Morton LM; Yasui YA; Sapkota YA; Arnold MA; Aubert G; Neglia JP; Turcotte LM; Leisenring WM; Sampson JN; Chanock SJ; Hudson MM; Armstrong GT; Robison LL; Bhatia S; Gramatges MM
    PLoS One; 2020; 15(2):e0228887. PubMed ID: 32040538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere Length-Associated Genetic Variants and the Risk of Thyroid Cancer in Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study (CCSS).
    Gramatges MM; Morton LM; Yasui Y; Arnold MA; Neglia JP; Leisenring WM; Machiela MJ; Dagnall CL; Chanock SJ; Armstrong GT; Robison LL; Bhatia S; Lupo PJ
    Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):417-419. PubMed ID: 30377209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short NK- and Naïve T-Cell Telomere Length Is Associated with Thyroid Cancer in Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study.
    Man TK; Aubert G; Richard MA; LeJeune W; Hariri E; Goltsova T; Gaikwad A; Chen Y; Whitton J; Leisenring WM; Arnold MA; Neglia JP; Yasui Y; Robison LL; Armstrong GT; Bhatia S; Gramatges MM
    Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):453-460. PubMed ID: 34782395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere content and risk of second malignant neoplasm in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
    Gramatges MM; Liu Q; Yasui Y; Okcu MF; Neglia JP; Strong LC; Armstrong GT; Robison LL; Bhatia S
    Clin Cancer Res; 2014 Feb; 20(4):904-11. PubMed ID: 24277454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
    Shi J; Yang XR; Ballew B; Rotunno M; Calista D; Fargnoli MC; Ghiorzo P; Bressac-de Paillerets B; Nagore E; Avril MF; Caporaso NE; McMaster ML; Cullen M; Wang Z; Zhang X; ; ; ; Bruno W; Pastorino L; Queirolo P; Banuls-Roca J; Garcia-Casado Z; Vaysse A; Mohamdi H; Riazalhosseini Y; Foglio M; Jouenne F; Hua X; Hyland PL; Yin J; Vallabhaneni H; Chai W; Minghetti P; Pellegrini C; Ravichandran S; Eggermont A; Lathrop M; Peris K; Scarra GB; Landi G; Savage SA; Sampson JN; He J; Yeager M; Goldin LR; Demenais F; Chanock SJ; Tucker MA; Goldstein AM; Liu Y; Landi MT
    Nat Genet; 2014 May; 46(5):482-6. PubMed ID: 24686846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer germline predisposing variants and late mortality from subsequent malignant neoplasms among long-term childhood cancer survivors: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor Study.
    Chen C; Qin N; Wang M; Dong Q; Tithi SS; Hui Y; Chen W; Wu G; Kennetz D; Edmonson MN; Rusch MC; Thrasher A; Easton J; Mulder HL; Song N; Plonski NM; Shelton K; Im C; Ehrhardt MJ; Nichols KE; Leisenring WM; Stratton KL; Howell R; Yasui Y; Bhatia S; Armstrong GT; Ness KK; Hudson MM; Zhang J; Wang H; Srivastava DK; Robison LL; Wang Z
    Lancet Oncol; 2023 Oct; 24(10):1147-1156. PubMed ID: 37797633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The enigma of excessively long telomeres in cancer: lessons learned from rare human POT1 variants.
    Gong Y; Stock AJ; Liu Y
    Curr Opin Genet Dev; 2020 Feb; 60():48-55. PubMed ID: 32155570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Truncating Germline Mutation of
    He H; Li W; Comiskey DF; Liyanarachchi S; Nieminen TT; Wang Y; DeLap KE; Brock P; de la Chapelle A
    Thyroid; 2020 Feb; 30(2):204-213. PubMed ID: 31928178
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of mutations of the telomerase RNA component in familial papillary thyroid cancer with short telomeres.
    Cantara S; Capuano S; Capezzone M; Benigni M; Pisu M; Marchisotta S; Pacini F
    Thyroid; 2012 Apr; 22(4):363-8. PubMed ID: 22304389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional diversity of human protection of telomeres 1 isoforms in telomere protection and cellular senescence.
    Yang Q; Zhang R; Horikawa I; Fujita K; Afshar Y; Kokko A; Laiho P; Aaltonen LA; Harris CC
    Cancer Res; 2007 Dec; 67(24):11677-86. PubMed ID: 18089797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline POT1 Deregulation Can Predispose to Myeloid Malignancies in Childhood.
    Michler P; Schedel A; Witschas M; Friedrich UA; Wagener R; Mehtonen J; Brozou T; Menzel M; Walter C; Nabi D; Pearce G; Erlacher M; Göhring G; Dugas M; Heinäniemi M; Borkhardt A; Stölzel F; Hauer J; Auer F
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma.
    Wong K; Robles-Espinoza CD; Rodriguez D; Rudat SS; Puig S; Potrony M; Wong CC; Hewinson J; Aguilera P; Puig-Butille JA; Bressac-de Paillerets B; Zattara H; van der Weyden L; Fletcher CDM; Brenn T; Arends MJ; Quesada V; Newton-Bishop JA; Lopez-Otin C; Bishop DT; Harms PW; Johnson TM; Durham AB; Lombard DB; Adams DJ
    JAMA Dermatol; 2019 May; 155(5):604-609. PubMed ID: 30586141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers.
    Wilson TL; Hattangady N; Lerario AM; Williams C; Koeppe E; Quinonez S; Osborne J; Cha KB; Else T
    Fam Cancer; 2017 Oct; 16(4):561-566. PubMed ID: 28389767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.
    Kim H; Yoo JE; Cho JY; Oh BK; Yoon YS; Han HS; Lee HS; Jang JJ; Jeong SH; Kim JW; Park YN
    J Hepatol; 2013 Oct; 59(4):746-52. PubMed ID: 23685049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial Clonal Hematopoiesis in a Long Telomere Syndrome.
    DeBoy EA; Tassia MG; Schratz KE; Yan SM; Cosner ZL; McNally EJ; Gable DL; Xiang Z; Lombard DB; Antonarakis ES; Gocke CD; McCoy RC; Armanios M
    N Engl J Med; 2023 Jun; 388(26):2422-2433. PubMed ID: 37140166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subsequent malignant neoplasms in survivors of childhood cancer: Childhood Cancer Survivor Study (CCSS) studies.
    Davies SM
    Pediatr Blood Cancer; 2007 Jun; 48(7):727-30. PubMed ID: 17243132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.
    Friedman DL; Whitton J; Leisenring W; Mertens AC; Hammond S; Stovall M; Donaldson SS; Meadows AT; Robison LL; Neglia JP
    J Natl Cancer Inst; 2010 Jul; 102(14):1083-95. PubMed ID: 20634481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility.
    Hosgood HD; Cawthon R; He X; Chanock S; Lan Q
    Lung Cancer; 2009 Nov; 66(2):157-61. PubMed ID: 19285750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent emergence and extinction of the protection of telomeres 1c gene in Arabidopsis thaliana.
    Kobayashi CR; Castillo-González C; Survotseva Y; Canal E; Nelson ADL; Shippen DE
    Plant Cell Rep; 2019 Sep; 38(9):1081-1097. PubMed ID: 31134349
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Shen E; Xiu J; Lopez GY; Bentley R; Jalali A; Heimberger AB; Bainbridge MN; Bondy ML; Walsh KM
    J Med Genet; 2020 Oct; 57(10):664-670. PubMed ID: 31937561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.